We are incredibly excited to share with you that Noscendo GmbH has been given a prestigious award as an “Employer Of The Future” from the Deutsche Innovationsinstitut für Nachhaltigkeit und Digitalisierung – DIND (The German Innovation Institute for Sustainability and Digitization – DIND). This is in cooperation with Germany’s largest business magazine DUP UNTERNEHMER (German Entrepreneur Platform).
Christina Koumourzi-Ridil, our VP People, said “Our people are Noscendo’s most valuable asset and we are on a mission to keep attracting top talent that can help us succeed in revolutionising infection diagnostics and in turn helping to saving patient lives, with DISQVER.”
DISQVER simultaneously identifies more than 16,000 microbes in just one blood sample, including 1,500 described pathogenic bacteria, DNA viruses, fungi and parasites*. Next-generation sequencing (NGS) is used to sequence the cell-free DNA in the patient’s blood. DISQVER matches this information with Noscendo’s clinical genome database using bioinformatics algorithms. Within 24 hours of receipt of the sample in the laboratory, the analysis is available and provides precise results on all relevant pathogens found in the blood.
View open opportunities at Noscendo: www.noscendo.com/career/
To learn more about DIND: www.dind.info
To learn more about DUP magazine: www.dup-magazin.de/
*Scientific studies on DISQVER® can be found under Publications.
